MX2024001972A - Métodos y composiciones para tratar condiciones de hígado fibrótico, usando composiciones de udenafil - Google Patents

Métodos y composiciones para tratar condiciones de hígado fibrótico, usando composiciones de udenafil

Info

Publication number
MX2024001972A
MX2024001972A MX2024001972A MX2024001972A MX2024001972A MX 2024001972 A MX2024001972 A MX 2024001972A MX 2024001972 A MX2024001972 A MX 2024001972A MX 2024001972 A MX2024001972 A MX 2024001972A MX 2024001972 A MX2024001972 A MX 2024001972A
Authority
MX
Mexico
Prior art keywords
compositions
fibrotic
liver
udenafil
fibrotic liver
Prior art date
Application number
MX2024001972A
Other languages
English (en)
Spanish (es)
Inventor
David J Goldberg
Mark W Russell
Kurt R Schumacher
James L Yeager
Original Assignee
Mezzion Pharma Co Ltd
David J Goldberg
Mark W Russell
Kurt R Schumacher
James L Yeager
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Mezzion Pharma Co Ltd, David J Goldberg, Mark W Russell, Kurt R Schumacher, James L Yeager filed Critical Mezzion Pharma Co Ltd
Publication of MX2024001972A publication Critical patent/MX2024001972A/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
MX2024001972A 2021-08-13 2024-02-13 Métodos y composiciones para tratar condiciones de hígado fibrótico, usando composiciones de udenafil MX2024001972A (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US202163233133P 2021-08-13 2021-08-13
PCT/US2022/040227 WO2023018972A1 (en) 2021-08-13 2022-08-12 Methods and compositions for treating fibrotic liver conditions, using udenafil compositions

Publications (1)

Publication Number Publication Date
MX2024001972A true MX2024001972A (es) 2024-11-08

Family

ID=83355014

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2024001972A MX2024001972A (es) 2021-08-13 2024-02-13 Métodos y composiciones para tratar condiciones de hígado fibrótico, usando composiciones de udenafil

Country Status (7)

Country Link
US (2) US20230218622A1 (https=)
EP (1) EP4384176A1 (https=)
JP (1) JP2024532957A (https=)
AU (1) AU2022325803A1 (https=)
CA (1) CA3229274A1 (https=)
MX (1) MX2024001972A (https=)
WO (1) WO2023018972A1 (https=)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US12396708B2 (en) * 2024-01-08 2025-08-26 Echosens Sa Method for determining an index for assessing a cardiac function of a subject
EP4582017A1 (en) * 2024-01-08 2025-07-09 Echosens Method for determining an index for assessing a cardiac function of a subject

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0202254D0 (en) * 2002-01-31 2002-03-20 Pfizer Ltd Prevention of scarring
PT1888074E (pt) * 2005-06-10 2012-03-01 Dong A Pharm Co Ltd Agente para a prevenção e tratamento de doenças do fígado contendo um derivado de pirazolopirimidina
TN2017000029A1 (en) 2014-08-12 2018-07-04 Mezzion Pharma Co Ltd Methods of improving myocardial performance in fontan patients using udenafil compositions

Also Published As

Publication number Publication date
AU2022325803A1 (en) 2024-03-28
EP4384176A1 (en) 2024-06-19
WO2023018972A1 (en) 2023-02-16
US20250186448A1 (en) 2025-06-12
US20230218622A1 (en) 2023-07-13
CA3229274A1 (en) 2023-02-16
JP2024532957A (ja) 2024-09-10

Similar Documents

Publication Publication Date Title
MX2024001972A (es) Métodos y composiciones para tratar condiciones de hígado fibrótico, usando composiciones de udenafil
EP4706638A3 (en) Methods of treating heart failure by administering omecamtiv mecarbil
MX2023012875A (es) Inhibidores 2-fluoro alquil-l,3,4-oxadiazol-5-il-tiazol de hdac6 para su uso en el tratamiento de enfermedades metabólicas y hfpef.
AU2021322255A8 (en) Use of dexpramipexole for the treatment of moderate to severe asthma
MX2022012310A (es) Metodos para tratar la esclerosis multiple recidivante con un inhibidor de tirosina quinasa de bruton.
MD523G2 (ro) Derivaţi noi ai triazolpirimidinei, antagonişti ai receptorilor angiotensinei II, procedee de preparare a lor, compoziţii farmaceutice ce le conţin
PH12015502465A1 (en) Use of landiolol hydrochloride in the long-term treatment of tachyarrhythmias
WO2021242844A8 (en) Grk2 inhibitors and uses thereof
Petzold et al. Hyperbaric oxygen therapy in deep sternal wound infection after heart transplantation
MX2025003110A (es) Metodo para tratar vih con cabotegravir y rilpivirina en pacientes pediatricos
ZA202311241B (en) Pharmaceutical composition comprising 1-(3-cyano-1-isopropyl-indol-5-yl)pyrazole-4-carboxylic acid
CA3168207A1 (en) Cellular uptake
JP2022550734A5 (https=)
WO2006104086A1 (ja) 血栓症治療剤
WO2024006971A3 (en) Antimalarial compounds
WO2022171732A9 (en) Composition and method for reducing oxalate levels in patients receiving maintenance dialysis
RU2252754C2 (ru) Применение карипорида для уменьшения нежелательных воздействий макролидных антибиотиков при ишемии и реперфузии сердца
WO2022106819A3 (en) Pharmaceutical composition for use in the prevention or treatment of a condition associated with a reduction in the number of lactobacilli in the vagina
HUP0301451A2 (hu) CGMP PDE5 inhibitorok alkalmazása perifériás érbetegségek, perifériás neuropátiák és autonóm neuropátiák kezelésére szolgáló gyógyszerkészítmények elżállítására
MX2023005663A (es) Tratamientos respiratorios.
US20180147140A1 (en) Treatment and Prevention of ENT Infections
ATE207353T1 (de) Verwendung von benzydamin zur behandlung von krankheitszuständen, die durch tnf verursacht werden
Wyatt et al. Let's get serious about promoting physical activity
MX2024007796A (es) Métodos y composiciones para mejorar el rendimiento en el ejercicio.
RU2021132757A (ru) Фармацевтическая композиция, содержащая дигидрокверцетин, трутневый расплод, витамин Д3, применение для профилактики и лечения сердечно-сосудистых патологий